The role of oxytocin in cardiovascular regulation

Oliver G, 1895, On the physiological action of extracts of pituitary body and certain other glandular organs: preliminary communication, J Physiol, 18, 277, 10.1113/jphysiol.1895.sp000565

Dale HH, 1906, On some physiological actions of ergot, J Physiol, 34, 163, 10.1113/jphysiol.1906.sp001148

Dale HH, 1909, The action of extracts of the pituitary body, Biochem J, 4, 427, 10.1042/bj0040427

Woodbury AR, 1940, Blood pressure studies of the effects of pituitary preparations on the human, Am J Physiol, 129, 500

Woodbury RA, 1944, Cardiac and blood pressure effects of pitocin (oxytocin) in man, J Pharmacol, 81, 95

Nakano J, 1963, Studies on the cardiovascular effects of synthetic oxytocin, J Pharmacol Exp Ther, 142, 206

Ott I, 1910, The action of infundibulin upon the mammary secretion, Proc Soc Exp Biol Med, 8, 48, 10.3181/00379727-8-27

Paton DN, 1912, The actions of pituitrin, adrenalin and barium on the circulation of the bird, J Physiol, 44, 413, 10.1113/jphysiol.1912.sp001523

von den Velden R, 1913, [Die Nierenwirkung von Hypophysenextrakten beim Menschen], Klin Wochschr, 50, 2083

Van Dyke HB, 1953, The regulation of water excretion by the neurohypophysis, Bull N Y Acad Med, 29, 24

Du Vigneaud V, 1953, The sequence of amino acids in oxytocin, with a proposal for the structure of oxytocin, J Biol Chem, 205, 949, 10.1016/S0021-9258(18)49238-1

Du Vigneaud V, 1956, Trail of sulfur research: from insulin to oxytocin, Science, 123, 967, 10.1126/science.123.3205.967

Zhang H, 2013, Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models, PLoS One, 8, e61477, 10.1371/journal.pone.0061477

Sofroniew MV, 1981, Immunohistochemistry of vasopressin, oxytocin and neurophysin in the hypothalamus and extrahypothalamic regions of the human and primate brain, Acta Histochem Suppl, 24, 79

Gaida W, 1985, Altered neuropeptide concentrations in spontaneously hypertensive rats: cause or consequence?, Clin Sci, 68, 35, 10.1042/cs0680035

Van Tol HH, 1988, Vasopressin and oxytocin gene expression in the supraoptic and paraventricular nucleus of the spontaneously hypertensive rat (SHR) during development of hypertension, Brain Res, 464, 303, 10.1016/0169-328X(88)90039-3

de Bold AJ, 1981, A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats, Life Sci, 28, 89, 10.1016/0024-3205(81)90370-2

Gutkowska J, 1997, Atrial natriuretic peptide in brain and pituitary gland, Physiol Rev, 77, 465, 10.1152/physrev.1997.77.2.465

Baldissera S, 1989, Role of the hypothalamus in the control of atrial natriuretic peptide release, Proc Natl Acad Sci U S A, 86, 9621, 10.1073/pnas.86.23.9621

Antunes-Rodrigues J, 1991, Lesions of the hypothalamus and pituitary inhibit volume-expansion-induced release of atrial natriuretic peptide, Proc Natl Acad Sci U S A, 88, 2956, 10.1073/pnas.88.7.2956

Haanwinckel MA, 1995, Oxytocin mediates atrial natriuretic peptide release and natriuresis after volume expansion in the rat, Proc Natl Acad Sci U S A, 92, 7902, 10.1073/pnas.92.17.7902

Soares TJ, 1999, Atrial natriuretic peptide and oxytocin induce natriuresis by release of cGMP, Proc Natl Acad Sci U S A, 96, 278, 10.1073/pnas.96.1.278

Favaretto AL, 1997, Oxytocin releases atrial natriuretic peptide from rat atria in vitro that exerts negative inotropic and chronotropic action, Peptides, 18, 1377, 10.1016/S0196-9781(97)00209-X

Gutkowska J, 1997, Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart, Proc Natl Acad Sci U S A, 94, 11704, 10.1073/pnas.94.21.11704

Jankowski M, 1998, Rat heart: a site of oxytocin production and action, Proc Natl Acad Sci U S A, 95, 14558, 10.1073/pnas.95.24.14558

Jankowski M, 2000, Oxytocin and its receptors are synthesized in the rat vasculature, Proc Natl Acad Sci U S A, 97, 6207, 10.1073/pnas.110137497

Adan RA, 1995, The rat oxytocin receptor. cDNA cloning and immunocytochemical localization in brain, pituitary, mammary gland and uterus, Adv Exp Med Biol, 395, 345

Cicutti NJ, 1999, Oxytocin receptor binding in rat and human heart, Can J Cardiol, 15, 1267

Jankowski M, 2004, Oxytocin in cardiac ontogeny, Proc Natl Acad Sci U S A, 101, 13074, 10.1073/pnas.0405324101

Zingg HH, 2003, The oxytocin receptor, Trends Endocrinol Metab, 14, 222, 10.1016/S1043-2760(03)00080-8

Szeto A, 2008, Oxytocin attenuates NADPH-dependent superoxide activity and IL-6 secretion in macrophages and vascular cells, Am J Physiol Endocrinol Metab, 295, E1495, 10.1152/ajpendo.90718.2008

Cattaneo MG, 2009, Oxytocin stimulates in vitroangiogenesis via a Pyk-2/Src-dependent mechanism, Exp Cell Res, 315, 3210, 10.1016/j.yexcr.2009.06.022

Noiseux N, 2012, Preconditioning of stem cells by oxytocin to improve their therapeutic potential, Endocrinology, 153, 5361, 10.1210/en.2012-1402

Florian M, 2010, Oxytocin increases glucose uptake in neonatal rat cardiomyocytes, Endocrinology, 151, 482, 10.1210/en.2009-0624

Kobayashi H, 2009, Postinfarct treatment with oxytocin improves cardiac function and remodeling via activating cell-survival signals and angiogenesis, J Cardiovasc Pharmacol, 54, 510, 10.1097/FJC.0b013e3181bfac02

Jankowski M, 2010, Anti-inflammatory effect of oxytocin in rat myocardial infarction, Basic Res Cardiol, 105, 205, 10.1007/s00395-009-0076-5

Jankowski M, 2010, Cardiac oxytocin receptor blockade stimulates adverse cardiac remodeling in ovariectomized spontaneously hypertensive rats, Am J Physiol Heart Circ Physiol, 299, H265, 10.1152/ajpheart.00487.2009

Paquin J, 2002, Oxytocin induces differentiation of P19 embryonic stem cells to cardiomyocytes, Proc Natl Acad Sci U S A, 99, 9550, 10.1073/pnas.152302499

Oyama T, 2007, Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro andin vivo, J Cell Biol, 176, 329, 10.1083/jcb.200603014

Matsuura K, 2004, Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes, J Biol Chem, 279, 11384, 10.1074/jbc.M310822200

Gutkowska J, 2007, Effect of exercise training on cardiac oxytocin and natriuretic peptide systems in ovariectomized rats, Am J Physiol Regul Integr Comp Physiol, 293, R267, 10.1152/ajpregu.00071.2007

Indrambarya T, 2009, Low-dose vasopressin infusion results in increased mortality and cardiac dysfunction following ischemia-reperfusion injury in mice, Crit Care, 13, R98, 10.1186/cc7930

Alizadeh AM, 2011, Role of endogenous oxytocin in cardiac ischemic preconditioning, Regul Pept, 167, 86, 10.1016/j.regpep.2010.11.004

Wsol A, 2009, Central oxytocin modulation of acute stress-induced cardiovascular responses after myocardial infarction in the rat, Stress, 12, 517, 10.3109/10253890802687688

Nation DA, 2010, Oxytocin attenuates atherosclerosis and adipose tissue inflammation in socially isolated ApoE-/- mice, Psychosom Med, 72, 376, 10.1097/PSY.0b013e3181d74c48

Norman GJ, 2011, Oxytocin increases autonomic cardiac control: moderation by loneliness, Biol Psychol, 86, 174, 10.1016/j.biopsycho.2010.11.006

Kasama S, 2008, Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction, Eur Heart J, 29, 1485, 10.1093/eurheartj/ehn206

Ishii H, 2008, Pharmacological intervention for prevention of left ventricular remodeling and improving prognosis in myocardial infarction, Circulation, 118, 2710, 10.1161/CIRCULATIONAHA.107.748772

Mukaddam-Daher S, 2001, Negative inotropic and chronotropic effects of oxytocin, Hypertension, 38, 292, 10.1161/01.HYP.38.2.292

Ondrejcakova M, 2009, Oxytocin exerts protective effects on in vitro myocardial injury induced by ischemia and reperfusion, Can J Physiol Pharmacol, 87, 137

Ovize M, 2010, Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology, Cardiovasc Res, 87, 406, 10.1093/cvr/cvq129

Beauloye C, 2011, AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure, Cardiovasc Res, 90, 224, 10.1093/cvr/cvr034

Skyschally A, 2008, Pathophysiology of myocardial infarction: protection by ischemic pre- and postconditioning, Herz, 33, 88, 10.1007/s00059-008-3101-9

Das B, 2012, Is preconditioning by oxytocin administration mediated by iNOS and/or mitochondrial K(ATP) channel activation in thein vivo anesthetized rabbit heart?, Life Sci, 90, 763, 10.1016/j.lfs.2012.03.030

Tsutsui H, 2011, Oxidative stress and heart failure, Am J Physiol Heart Circ Physiol, 301, H2181, 10.1152/ajpheart.00554.2011

Wiemann M, 1993, Subcellular localization of immunoreactive oxytocin within thymic epithelial cells of the male mouse, Cell Tissue Res, 273, 79, 10.1007/BF00304614

Ndiaye K, 2008, Expression and regulation of functional oxytocin receptors in bovine T lymphocytes, Biol Reprod, 78, 786, 10.1095/biolreprod.107.065938

Martens H, 1998, Neurohypophysial peptides stimulate the phosphorylation of pre-T cell focal adhesion kinases, Neuroendocrinology, 67, 282, 10.1159/000054324

Oliveira-Pelegrin GR, 2013, Oxytocin affects nitric oxide and cytokine production by sepsis-sensitized macrophages, Neuroimmunomodulation, 20, 65, 10.1159/000345044

Detillion CE, 2004, Social facilitation of wound healing, Psychoneuroendocrinology, 29, 1004, 10.1016/j.psyneuen.2003.10.003

Iseri SO, 2005, Oxytocin protects against sepsis-induced multiple organ damage: role of neutrophils, J Surg Res, 126, 73, 10.1016/j.jss.2005.01.021

Petersson M, 2001, Oxytocin decreases carrageenan induced inflammation in rats, Peptides, 22, 1479, 10.1016/S0196-9781(01)00469-7

Amico JA, 2004, Anxiety and stress responses in female oxytocin deficient mice, J Neuroendocrinol, 16, 319, 10.1111/j.0953-8194.2004.01161.x

Bodi V, 2008, Uncontrolled immune response in acute myocardial infarction: unraveling the thread, Am Heart J, 156, 1065, 10.1016/j.ahj.2008.07.008

Al-Amran F, 2013, Oxytocin ameliorates the immediate myocardial injury in rat heart transplant through downregulation of neutrophil-dependent myocardial apoptosis, Transplant Proc, 45, 2506, 10.1016/j.transproceed.2013.03.022

Dorge H, 2002, Coronary microembolization: the role of TNF-alpha in contractile dysfunction, J Mol Cell Cardiol, 34, 51, 10.1006/jmcc.2001.1489

Ebermann L, 2009, Impact of myocardial inflammation on cytosolic and mitochondrial creatine kinase activity and expression, Basic Res Cardiol, 104, 247, 10.1007/s00395-008-0773-5

Frantz S, 2008, Transforming growth factor beta inhibition increases mortality and left ventricular dilatation after myocardial infarction, Basic Res Cardiol, 103, 485, 10.1007/s00395-008-0739-7

Frangogiannis NG, 2008, The immune system and cardiac repair, Pharmacol Res, 58, 88, 10.1016/j.phrs.2008.06.007

Abdel-Latif A, 2008, TGF-beta1 enhances cardiomyogenic differentiation of skeletal muscle-derived adult primitive cells, Basic Res Cardiol, 103, 514, 10.1007/s00395-008-0729-9

Green L, 2001, Oxytocin and autistic disorder: alterations in peptide forms, Biol Psychiatry, 50, 609, 10.1016/S0006-3223(01)01139-8

Gassanov N, 2008, Functional activity of the carboxyl-terminally extended oxytocin precursor peptide during cardiac differentiation of embryonic stem cells, Stem Cells, 26, 45, 10.1634/stemcells.2007-0289

Gutkowska J, 2012, Oxytocin revisited: its role in cardiovascular regulation, J Neuroendocrinol, 24, 599, 10.1111/j.1365-2826.2011.02235.x

Gutkowska J, 2000, Oxytocin is a cardiovascular hormone, Braz J Med Biol Res, 33, 625, 10.1590/S0100-879X2000000600003

McCann SM, 2002, Oxytocin, vasopressin and atrial natriuretic peptide control body fluid homeostasis by action on their receptors in brain, cardiovascular system and kidney, Prog Brain Res, 139, 309, 10.1016/S0079-6123(02)39027-7